Telesis Bio Stock (NASDAQ: TBIO) stock price, news, charts, stock research, profile.
Open | $0.329 |
Close | $0.321 |
Volume / Avg. | 23.578K / 759.045K |
Day Range | 0.312 - 0.340 |
52 Wk Range | 0.300 - 3.010 |
Market Cap | $10.467M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 1.83% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Telesis Bio (NASDAQ: TBIO) through any online brokerage.
Other companies in Telesis Bio’s space includes: Harvard Bioscience (NASDAQ:HBIO), Personalis (NASDAQ:PSNL), Applied DNA Sciences (NASDAQ:APDN), Inotiv (NASDAQ:NOTV) and Lifecore Biomedical (NASDAQ:LFCR).
The latest price target for Telesis Bio (NASDAQ: TBIO) was reported by Keybanc on Friday, August 11, 2023. The analyst firm set a price target for 0.00 expecting TBIO to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Telesis Bio (NASDAQ: TBIO) is $0.3477 last updated Today at April 25, 2024 at 4:35 PM EDT.
There are no upcoming dividends for Telesis Bio.
Telesis Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Telesis Bio.
Telesis Bio is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.